Tanaka N, Izumi K, Nakai Y, Shima T, et al. Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa. Prostate 2024 Sep 20. doi: 10.1002/pros.24796.
PMID: 39301921